InvestorsHub Logo
Followers 23
Posts 3078
Boards Moderated 0
Alias Born 07/15/2016

Re: None

Tuesday, 11/07/2017 10:34:27 AM

Tuesday, November 07, 2017 10:34:27 AM

Post# of 65785
Nothing crazy from the 8-k I've quoted below, but IMHO I think these types of 8-ks are more powerful than PR as they answer many questions asked by shareholders directly.

As for Q1 and Q2 this is news to me and should have been conveyed at the time of acquisition. We all fear dilution and here we see that no major capital investment was made. This is excellent.

Q4 - OK not a big thing on my list. EVIO already got paid and we won't be bringing in massive revenue from the FL license agreement.

Q5 - about time we hear something from Mass. That lab was not cheap. Is regulated testing as big as in OR? Seems like Mass has the same revenue potential as OR.

Lacking.... What's the CO 'license agreement' all about?

Hey maybe the pref Ds are all cashed out by now?

The Company has received questions and the Company felt it was better to answer the questions through an 8-K instead emailing the individuals directly.

Q1. What is the status of the lab in Eastern Oregon?

A. The lab located in La Grande, Oregon, which is four hour drive away from both our existing Portland and Bend locations, will serve as our regional spoke serving both industrial hemp and cannabis clients in Eastern Oregon.

Q2. What stock and/or cash issued in conjunction with the opening of the laboratory.

A. This facility was an organic expansion of our business operations in Oregon. The location itself was the prior home of Eastern Oregon Analytical, a non-licensed medical cannabis testing facility. Other than a monthly rental agreement of $700 per month; no stock, cash or other debenture was issued as part of this expansion.

Q3. What are the hours of the facility.

A. The Eastern Oregon laboratory is being managed by our client services team out of our Bend location. The facility is currently open on an appointment only basis, and will be staffed on a more permanent basis during the harvest seasons.

Q4. When will the Florida Laboratory be open?

A. Our Florida licensee is fully staffed, has completed facility build-out, and is in the process of installing and configuring equipment. The EVIO team will be spending the next month training Florida laboratory personnel on our accredited methods. Upon completion, of training, we anticipate the laboratory will receive its provisional testing license from the State of Florida during the Fourth Quarter of 2017.

Q5. How has the Massachusetts lab been performing since the acquisition?

A. EVIO Labs Massachusetts (formerly known as Viridis Analytics) is continuing to see its demand for testing services increase. Since the acquisition, demand for our services has continued to increase. There are currently 15 licensed Registered Marijuana Dispensaries operating in Massachusetts up from the 11 when we acquired Viridis. The number of pending licensees has increased from 101 to over 220 according to the Massachusetts Department of Health. Recreational marijuana will be available in the state commencing in July 2018. Many of our clients are already preparing for this forecasted increase in demand.